Source: HVMN

13 days after publishing a paper on hydroxychloroquine (a potential drug for coronavirus treatment), The Lancet retracted the study due to faulty data. 

In the midst of a global pandemic, the study (that have since been retracted) was used as a basis for the guidelines set by the WHO, the CDC, elected officials, and…well, let’s see how deep this rabbit hole leads us by the man who helped break the story.

Our guest today, James Todaro, MD, played a significant role in this multi-layered scandal: By revealing the red flags of a study published by one of the world’s oldest and best-known medical journals, and causing The Lancet to retract it in just 13 days.

Buckle up and enjoy this episode of the H.V.M.N. Podcast. You can follow Dr. Todaro on Twitter and his ongoing work here 👉 https://twitter.com/JamesTodaroMD




Related: Dr James Todaro: An Effective Treatment for Coronavirus (COVID-19) – Previously Censored.

Why That Observational Study of Hydroxychloroquine in The Lancet Seems Fishy

LancetGate: Surgisphere – is the company which provided the data to the study serious?

Lancet HCQ, A Study Out of Thin Air

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Professor Borody Talks about Early Treatment of COVID-19 – Part 1 – September 2020

We treat them for 10 days using an appropriate dose of ivermectin, doxycycline daily and zinc daily.

They all actually have activity against the intracellular multiplication of the virus and from published data you can read that most of the results have been close to 100 percent cure there was one that used the lower level and got 92 percent cure but it’s just hard to believe how simple it is to cure coronavirus.

Read More »